Positive Medicaid signals, open enrollment trends: Recapping major payers' Q3 results

UnitedHealth Group reported Q3 profit of $4.1B (up from $2.3B YoY) and revenue of $112.7B. CVS Health earned $2.2B (up from a $4B loss YoY) on $108.4B revenue, announcing a split of its pharmacy business. Cigna and Elevance Health each posted $1.4B profit. Centene reduced losses to $71M (from $6.6B YoY) on $50.6B revenue. Humana saw $162M profit (down from $195M) on $41.15B revenue, with positive Medicare enrollment trends.

Original reporting
Published Nov 10, 2026, 6:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$UNH
Bullish
high confidence
Mentioned
$UNH · $CVS · $CI · $ELV · $CNC · $HUM
Relevance
8/10
AlphAI data visualization · based on fiercehealthcare.com
Decision brief

The 30-second read

$UNHBullishHigh
01

Why it matters

Earnings releases provide fresh data on profitability, revenue trends, and strategic restructurings, shaping short‑term price action and sector sentiment.

02

Market read

First‑report Q3 earnings for six major insurers, each with material profit or loss changes, drive immediate trading opportunities.

03

What to watch

Regulatory Medicaid rate changes could affect future earnings beyond the reported quarter.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

Q3 2026 earnings season for major U.S. health insurers, with several companies reporting profit turnarounds and strategic moves.

Company-level read

Ticker impact

$UNHBullishHigh confidence
Context

UnitedHealth Group reported Q3 profit of $4.1 billion, up from $2.3 billion a year ago, and revenue of $112.7 billion.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

First‑report earnings numbers show strong profit growth and revenue resilience.

$CVSBullishHigh confidence
Context

CVS Health posted Q3 profit of $2.2 billion after a $4 billion loss a year earlier and revenue of $108.4 billion.

Expected impact

potential upside as investors reward the profit reversal

Evidence & confidence

First‑report earnings reveal a dramatic profit swing and a strategic split announcement.

$CINeutralMedium confidence
Context

Cigna reported Q3 profit of $1.4 billion and revenue of $73.7 billion, beating prior‑year profit of $1.9 billion.

Expected impact

moderate pressure as profit fell despite revenue growth

Evidence & confidence

First‑report earnings show profit contraction, limiting upside.

$ELVNeutralMedium confidence
Context

Elevance Health posted Q3 profit of $1.4 billion, up from $1.2 billion a year ago, with revenue of $51.4 billion.

Expected impact

limited move, likely sideways as growth is modest

Evidence & confidence

First‑report earnings but modest incremental change.

$CNCBullishHigh confidence
Context

Centene reported a Q3 loss of $71 million, a sharp improvement from a $6.6 billion loss a year earlier, with revenue of $50.6 billion.

Expected impact

upward pressure as the loss narrowing is substantial

Evidence & confidence

First‑report earnings show dramatic turnaround in loss magnitude.

$HUMNeutralMedium confidence
Context

Humana posted Q3 profit of $162 million, down from $195 million a year ago, and revenue of $41.15 billion.

Expected impact

potential slight downside as profit fell

Evidence & confidence

First‑report earnings but profit contraction tempers enthusiasm.

Market effects

Health‑care payer sector may see broader rally on strong earnings trends.

U.S. market likely to open higher in health‑care indices.

Large insurer results influence global insurance sentiment and capital allocation.

Counterpoint

Profit growth may be overstated if cost pressures intensify; watch for margin compression.

Key entities

  • UnitedHealth Group

    Largest U.S. health insurer, reported strong Q3 earnings.

  • CVS Health

    Pharmacy and health services firm, announced split and earnings beat.

  • Cigna

    Health insurer with mixed earnings results.

  • Elevance Health

    Health insurer with modest profit improvement.

  • Centene

    Insurer showing dramatic loss reduction.

Related articles

$CVSMed

CVS Health announces plan to split into two companies

CVS Health plans to split into two publicly traded companies by early 2028, separating its retail pharmacy business from Aetna and CVS Caremark. The move follows a Tennessee law targeting healthcare giants like CVS, which owns both a pharmacy benefit manager and retail pharmacies. CVS is suing the state, claiming the law is unconstitutional. The company states the restructuring will not affect its Tennessee pharmacies or clinics.

$CVSMed

The impact of the CVS split in WV

CVS plans to split into two entities by 2028, separating its insurance and PBM operations from its retail pharmacy business. The company aims to improve focus, respond to regulatory pressure, and unlock value. According to Paul Pruitt, co-founder of SHARKx, the split may lead to more sustainable long-term strategies for CVS. The company stated that the separation should not impact customers.

$HUMHighAI 9/10

Humana (HUM) Stock Hits New 52-Week High

Humana (HUM) reached a new 52-week high after reporting Q3 2026 earnings with a smaller loss and raised full-year EPS guidance. Competitors like CVS Health and Elevance Health also saw gains. Clover Health (CLOV) reported Q3 2026 earnings with a slight profit and raised full-year targets.